| 000 | 01055 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512195823.0 | ||
| 264 | 0 | _c19830214 | |
| 008 | 198302s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(82)91272-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarkness, J A | |
| 245 | 0 | 0 |
_aPenicillamine nephropathy and iron. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cDec 1982 |
||
| 300 |
_a1368-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aGlomerulonephritis _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 |
_aIron _xadministration & dosage |
| 650 | 0 | 4 |
_aPenicillamine _xadverse effects |
| 700 | 1 | _aBlake, D R | |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8312 _gp. 1368-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(82)91272-7 _zAvailable from publisher's website |
| 999 |
_c6129550 _d6129550 |
||